These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22681249)

  • 1. Functional selectivity in GPCR heterocomplexes.
    González-Maeso J; Sealfon SC
    Mini Rev Med Chem; 2012 Aug; 12(9):851-5. PubMed ID: 22681249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional selectivity in GPCR signaling: understanding the full spectrum of receptor conformations.
    Goupil E; Laporte SA; Hébert TE
    Mini Rev Med Chem; 2012 Aug; 12(9):817-30. PubMed ID: 22681252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional signaling biases in G protein-coupled receptors: Game Theory and receptor dynamics.
    Maudsley S; Patel SA; Park SS; Luttrell LM; Martin B
    Mini Rev Med Chem; 2012 Aug; 12(9):831-40. PubMed ID: 22681251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential.
    Seyedabadi M; Ghahremani MH; Albert PR
    Pharmacol Ther; 2019 Aug; 200():148-178. PubMed ID: 31075355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring a role for heteromerization in GPCR signalling specificity.
    Rozenfeld R; Devi LA
    Biochem J; 2011 Jan; 433(1):11-8. PubMed ID: 21158738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adhesion G protein-coupled receptors: signaling, pharmacology, and mechanisms of activation.
    Paavola KJ; Hall RA
    Mol Pharmacol; 2012 Nov; 82(5):777-83. PubMed ID: 22821233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse agonism: the classic concept of GPCRs revisited [Review].
    Sato J; Makita N; Iiri T
    Endocr J; 2016 Jun; 63(6):507-14. PubMed ID: 26961122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities for functional selectivity in GPCR antibodies.
    Webb DR; Handel TM; Kretz-Rommel A; Stevens RC
    Biochem Pharmacol; 2013 Jan; 85(2):147-52. PubMed ID: 22975405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-protein-coupled designer receptors - new chemical-genetic tools for signal transduction research.
    Thiel G; Kaufmann A; Rössler OG
    Biol Chem; 2013 Dec; 394(12):1615-22. PubMed ID: 23893685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes.
    Smith NJ; Milligan G
    Pharmacol Rev; 2010 Dec; 62(4):701-25. PubMed ID: 21079041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse agonists: tools to reveal ligand-specific conformations of G protein-coupled receptors.
    Prather PL
    Sci STKE; 2004 Jan; 2004(215):pe1. PubMed ID: 14722344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational complexity of G-protein-coupled receptors.
    Kobilka BK; Deupi X
    Trends Pharmacol Sci; 2007 Aug; 28(8):397-406. PubMed ID: 17629961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-protein-coupled receptor heteromers or how neurons can display differently flavoured patterns in response to the same neurotransmitter.
    Franco R
    Br J Pharmacol; 2009 Sep; 158(1):23-31. PubMed ID: 19422387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RGS proteins destroy spare receptors: Effects of GPCR-interacting proteins and signal deamplification on measurements of GPCR agonist potency.
    Chidiac P
    Methods; 2016 Jan; 92():87-93. PubMed ID: 26297537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Versatility of GPCR recognition by drugs: from biological implications to therapeutic relevance.
    Bosier B; Hermans E
    Trends Pharmacol Sci; 2007 Aug; 28(8):438-46. PubMed ID: 17629964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How ligands and signalling proteins affect G-protein-coupled receptors' conformational landscape.
    Mary S; Fehrentz JA; Damian M; Verdié P; Martinez J; Marie J; Banères JL
    Biochem Soc Trans; 2013 Feb; 41(1):144-7. PubMed ID: 23356274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor.
    Hudson BD; Hébert TE; Kelly ME
    Mol Pharmacol; 2010 Jan; 77(1):1-9. PubMed ID: 19837905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective.
    Shonberg J; Lopez L; Scammells PJ; Christopoulos A; Capuano B; Lane JR
    Med Res Rev; 2014 Nov; 34(6):1286-330. PubMed ID: 24796277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining efficacy: exploiting functional selectivity for drug discovery.
    Gesty-Palmer D; Luttrell LM
    Adv Pharmacol; 2011; 62():79-107. PubMed ID: 21907907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of functional selectivity through G protein-dependent and -independent signaling pathways at the adrenergic α(2C) receptor.
    Kurko D; Kapui Z; Nagy J; Lendvai B; Kolok S
    Brain Res Bull; 2014 Aug; 107():89-101. PubMed ID: 25080296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.